Moreover, our study suggests that in early stage colorectal cancer stringent glucose control may be important for tumor progression, while in advanced stages of colon cancer inhibition of the endocrine actions of the IGFs and insulin are more important to restrain growth of colon cancer cells. This evidence concerns the gene INS and neoplasm.